| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6176503 | European Urology | 2015 | 10 Pages |
Abstract
Patients with visceral metastases should be considered as affected by more aggressive disease and might benefit from the inclusion in clinical trials evaluating novel molecules.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Giorgio Gandaglia, Pierre I. Karakiewicz, Alberto Briganti, Niccolò Maria Passoni, Jonas Schiffmann, Vincent Trudeau, Markus Graefen, Francesco Montorsi, Maxine Sun,